Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 7, 2014, after the close
10-Q filed Nov 7, 2014, 38 days after period end · 0001144204-14-065859
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $5.00K | $2.50K | $170.83K | $103.42K |
| Net Income | -$4.46M | -$6.69M | -$2.58M | -$3.21M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.05 |
| -$0.09 |
| -$0.04 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
